Abstract:We investigated the impact of bone marrow-derived mesenchymal stem cells (BM-MSCs) alone or in combination with hepatocyte growth factor (HGF) transplantation via noninfarct-relative artery in a swine myocardial infarction (MI) model. Donor BM-MSCs were derived in vitro from swine auto-bone marrow cultures labeled by bromodeoxyuridine (BrdU) incorporation. Host MI swine model was created by ligating the distal left anterior descending artery. After 4 weeks, age-matched male MI swines were used for the transplantation. Male MI swines were transfused via noninfarct-relative artery with vehicle (control, n =6) or BrdU-labeled BM-MSCs (5 × 10 6 ) alone (MSCs, n =6) or BrdU-labeled BM-MSCs (5 × 10 6 ) combined with HGF (4 × 10 9 PFU) (MSCs+HGF, n =6). To evaluate the collateral artery growth (Rentrop) and cardiac perfusion in these animals, gate cardiac perfusion imaging and coronary angiography were performed before and 4 weeks after transplantation, respectively. To assess the contribution of donor-originated cells in stimulation of cardiomyocyte regeneration and angiogenesis, immunohistochemistry for BrdU and α -smooth muscle actin ( α -SMA) and quantitative image analysis were performed at 4 weeks after transplantation. The results are as follows: (1) BrdU-positive cells were detected in host myocardium in both MSCs and MSCs+HGF groups, but not in the vehicle group. Most BrdU-positive cells expressed myosin heavy chain β . (2) α -SMA - positive arteriole densities in the infarcted border area and infarcted area were increased significantly in both transplantation groups compared with the vehicle group. (3) Gate cardiac perfusion imaging demonstrated that the cardiac perfusion was significantly improved in transplantation groups compared with the vehicle group. (4) Ejection fraction and α -SMA-positive arteriole densities were increased significantly in both transplantation groups compared with the vehicle group. However, there was no difference in ejection fraction and α -SMA-positive arteriole densities between the MSCs group and the MSCs+HGF group. Growth of collateral arteries was not detected by coronary angiography in all three groups. In conclusion, the current study indicates that BM-MSCs transplantation via noninfarct-relative artery stimulates cardiomyocyte regeneration and angiogenesis and improves cardiac function, but does not stimulate collateral artery growth. BM-MSCs transplantation combined with HGF therapy is not superior to BM-MSCs alone transplantation. BM-MSCs transplantation via noninfarct-relative artery may be an alternative for those patients who cannot be transplanted via infarct-relative artery in clinical practice.

Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs

The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure

Immediate Intraportal Transplantation of Human Bone Marrow Mesenchymal Stem Cells Prevents Death from Fulminant Hepatic Failure in Pigs

Return of the Metabolic Trajectory to the Original Area after Human Bone Marrow Mesenchymal Stem Cell Transplantation for the Treatment of Fulminant Hepatic Failure

Therapeutic Potential of Menstrual Blood Stem Cells in Treating Acute Liver Failure

Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction

A Metabonomics Study of Chinese Miniature Pigs with Acute Liver Failure Treated with Transplantation of Placental Mesenchymal Stem Cells

Mesenchymal stem cells prolong survival and prevent lethal complications in a porcine model of fulminant liver failure

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

Transplantation Routes and Mechanism of Mesenchymal Stem Cell Therapy in Porcine Models with Acute Liver Failure

Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation.

Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure

Transcriptional profiling and hepatogenic potential of acute hepatic failure-derived bone marrow mesenchymal stem cells.

Combined therapy of mesenchymal stem cell transplantation and interleukin 1 receptor antagonist for swine acute liver failure

Effects on swine acute liver failure by combined therapy of autologous mesenchymal stem cell transplantation and medical treatment

Significant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs.

The Beneficial Effect of Mesenchymal Stem Cells Transplantation in Combination with Interleukin-1 Receptor Antagonist on Post-Hepatectomy Liver Failure

Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure

Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction

Amniotic Fluid-Derived Mesenchymal Stem Cells As A Novel Therapeutic Approach in the Treatment of Fulminant Hepatic Failure in Rats

Combined mesenchymal stem cell transplantation and interleukin-1 receptor antagonism after partial hepatectomy.